This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: University of Innsbruck. Active years: 2014-2017.
Company Filing History:
Years Active: 2014-2017
Title: David Bernhard: Innovator in Pharmaceutical Compositions
Introduction
David Bernhard is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating hyperplastic diseases. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Bernhard's latest patents focus on pharmaceutical compositions comprising lignans and their derivatives. These compositions are designed for treating hyperplastic diseases, including conditions such as intimal hyperplasia, stenosis, restenosis, and atherosclerosis. One of the preferred compounds in his inventions is leoligin, which is derived from the plant Cass. (Edelweiss). The patents also describe corresponding means and methods for medical uses of these compounds, including their application in treating proliferative diseases like leukemia, prostate cancer, and lung cancer.
Career Highlights
Throughout his career, David Bernhard has worked with prestigious institutions, including the University of Innsbruck and the University of Münster. His research and innovations have contributed to advancements in the pharmaceutical field, particularly in the treatment of serious medical conditions.
Collaborations
Some of his notable coworkers include Hermann Stuppner and Stefan Schwaiger. Their collaborative efforts have further enhanced the research and development of pharmaceutical compositions.
Conclusion
David Bernhard's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments for hyperplastic and proliferative diseases. His work continues to influence the field and offers hope for effective therapies in the future.